Immunohistochemistry Market 2024-2028

Report
168 Pages
February 2024
Region: Global
TechNavio
ID: 4769243

The immunohistochemistry market is forecasted to grow by USD 1.06 billion during 2022-2027, accelerating at a CAGR of 7.52% during the forecast period. The report on the immunohistochemistry market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing number of cancer patients globally, the rising aging population, and mergers and acquisitions among immunohistochemistry market players.

The immunohistochemistry market is segmented as below:

By Application

Diagnostic application
Research application
Forensic application

By End-user

Hospitals and diagnostic laboratories
Academic and research institutes
Others

By Geographical Landscape

North America
Europe
APAC
Rest of World (ROW)

This study identifies the automation and digitalization of immunohistochemistry processes as one of the prime reasons driving the immunohistochemistry market growth during the next few years. Also, rise in demand for personalized medicine and increasing investment in healthcare industry will lead to sizable demand in the market.

The report on the immunohistochemistry market covers the following areas:

Immunohistochemistry market sizing
Immunohistochemistry market forecast
Immunohistochemistry market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunohistochemistry market vendors that include Agilent Technologies Inc., Bio Rad Laboratories Inc., Bio SB, Bio Techne Corp., Biocare Medical LLC, BioGenex Laboratories Inc., CANDOR Bioscience GmbH, Cell Signaling Technology Inc., Danaher Corp., Eagle Biosciences Inc., Elabscience Biotechnology Inc., F. Hoffmann La Roche Ltd., Lunaphore Technologies SA, Merck KGaA, Miltenyi Biotec B.V. and Co. KG, PerkinElmer Inc., Takara Holdings Inc., Thermo Fisher Scientific Inc., PHC Holdings Corp., and SAKURA SEIKI Co. Ltd.. Also, the immunohistochemistry market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global immunohistochemistry market 2018 - 2018
Exhibit 18: Historic Market Size - Data Table on global immunohistochemistry market 2018 - 2018 ($ billion)
4.2 Application Segment Analysis 2018 - 2018
Exhibit 19: Historic Market Size - Application Segment 2018 - 2018 ($ billion)
4.3 End-user Segment Analysis 2018 - 2018
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2018 ($ billion)
4.4 Geography Segment Analysis 2018 - 2018
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2018 ($ billion)
4.5 Country Segment Analysis 2018 - 2018
Exhibit 22: Historic Market Size - Country Segment 2018 - 2018 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

6.1 Market segments
Exhibit 30: Chart on Application - Market share 2023-2028 (%)
Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Diagnostic application - Market size and forecast 2023-2028
Exhibit 34: Chart on Diagnostic application - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Diagnostic application - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Diagnostic application - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Diagnostic application - Year-over-year growth 2023-2028 (%)
6.4 Research application - Market size and forecast 2023-2028
Exhibit 38: Chart on Research application - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Research application - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Research application - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Research application - Year-over-year growth 2023-2028 (%)
6.5 Forensic application - Market size and forecast 2023-2028
Exhibit 42: Chart on Forensic application - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Forensic application - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Forensic application - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Forensic application - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Application
Exhibit 46: Market opportunity by Application ($ billion)
Exhibit 47: Data Table on Market opportunity by Application ($ billion)

7 Market Segmentation by End-user

7.1 Market segments
Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 50: Chart on Comparison by End-user
Exhibit 51: Data Table on Comparison by End-user
7.3 Hospitals and diagnostic laboratories - Market size and forecast 2023-2028
Exhibit 52: Chart on Hospitals and diagnostic laboratories - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2023-2028 (%)
7.4 Academic and research institutes - Market size and forecast 2023-2028
Exhibit 56: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
7.5 Others - Market size and forecast 2023-2028
Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by End-user
Exhibit 64: Market opportunity by End-user ($ billion)
Exhibit 65: Data Table on Market opportunity by End-user ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 France - Market size and forecast 2023-2028
Exhibit 95: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on France - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Agilent Technologies Inc.
Exhibit 115: Agilent Technologies Inc. - Overview
Exhibit 116: Agilent Technologies Inc. - Business segments
Exhibit 117: Agilent Technologies Inc. - Key news
Exhibit 118: Agilent Technologies Inc. - Key offerings
Exhibit 119: Agilent Technologies Inc. - Segment focus
12.4 Bio SB
Exhibit 120: Bio SB - Overview
Exhibit 121: Bio SB - Product/Service
Exhibit 122: Bio SB - Key offerings
12.5 Biocare Medical LLC
Exhibit 123: Biocare Medical LLC - Overview
Exhibit 124: Biocare Medical LLC - Product/Service
Exhibit 125: Biocare Medical LLC - Key offerings
12.6 BioGenex Laboratories Inc.
Exhibit 126: BioGenex Laboratories Inc. - Overview
Exhibit 127: BioGenex Laboratories Inc. - Product/Service
Exhibit 128: BioGenex Laboratories Inc. - Key offerings
12.7 CANDOR Bioscience GmbH
Exhibit 129: CANDOR Bioscience GmbH - Overview
Exhibit 130: CANDOR Bioscience GmbH - Product/Service
Exhibit 131: CANDOR Bioscience GmbH - Key offerings
12.8 Cell Signaling Technology Inc.
Exhibit 132: Cell Signaling Technology Inc. - Overview
Exhibit 133: Cell Signaling Technology Inc. - Product/Service
Exhibit 134: Cell Signaling Technology Inc. - Key offerings
12.9 Danaher Corp.
Exhibit 135: Danaher Corp. - Overview
Exhibit 136: Danaher Corp. - Business segments
Exhibit 137: Danaher Corp. - Key news
Exhibit 138: Danaher Corp. - Key offerings
Exhibit 139: Danaher Corp. - Segment focus
12.10 Elabscience Biotechnology Inc.
Exhibit 140: Elabscience Biotechnology Inc. - Overview
Exhibit 141: Elabscience Biotechnology Inc. - Product/Service
Exhibit 142: Elabscience Biotechnology Inc. - Key offerings
12.11 F. Hoffmann La Roche Ltd.
Exhibit 143: F. Hoffmann La Roche Ltd. - Overview
Exhibit 144: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 145: F. Hoffmann La Roche Ltd. - Key news
Exhibit 146: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 147: F. Hoffmann La Roche Ltd. - Segment focus
12.12 Lunaphore Technologies SA
Exhibit 148: Lunaphore Technologies SA - Overview
Exhibit 149: Lunaphore Technologies SA - Product/Service
Exhibit 150: Lunaphore Technologies SA - Key offerings
12.13 Merck KGaA
Exhibit 151: Merck KGaA - Overview
Exhibit 152: Merck KGaA - Business segments
Exhibit 153: Merck KGaA - Key news
Exhibit 154: Merck KGaA - Key offerings
Exhibit 155: Merck KGaA - Segment focus
12.14 Miltenyi Biotec B.V. and Co. KG
Exhibit 156: Miltenyi Biotec B.V. and Co. KG - Overview
Exhibit 157: Miltenyi Biotec B.V. and Co. KG - Product/Service
Exhibit 158: Miltenyi Biotec B.V. and Co. KG - Key offerings
12.15 SAKURA SEIKI Co. Ltd.
Exhibit 159: SAKURA SEIKI Co. Ltd. - Overview
Exhibit 160: SAKURA SEIKI Co. Ltd. - Product/Service
Exhibit 161: SAKURA SEIKI Co. Ltd. - Key offerings
12.16 Takara Holdings Inc.
Exhibit 162: Takara Holdings Inc. - Overview
Exhibit 163: Takara Holdings Inc. - Business segments
Exhibit 164: Takara Holdings Inc. - Key offerings
Exhibit 165: Takara Holdings Inc. - Segment focus
12.17 Thermo Fisher Scientific Inc.
Exhibit 166: Thermo Fisher Scientific Inc. - Overview
Exhibit 167: Thermo Fisher Scientific Inc. - Business segments
Exhibit 168: Thermo Fisher Scientific Inc. - Key news
Exhibit 169: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 170: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 171: Inclusions checklist
Exhibit 172: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 173: Currency conversion rates for US$
13.4 Research methodology
Exhibit 174: Research methodology
Exhibit 175: Validation techniques employed for market sizing
Exhibit 176: Information sources
13.5 List of abbreviations
Exhibit 177: List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global immunohistochemistry market 2018 - 2018 ($ billion)
Exhibits 19: Historic Market Size - Application Segment 2018 - 2018 ($ billion)
Exhibits 20: Historic Market Size - End-user Segment 2018 - 2018 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2018 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2018 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Application - Market share 2023-2028 (%)
Exhibits 31: Data Table on Application - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Application
Exhibits 33: Data Table on Comparison by Application
Exhibits 34: Chart on Diagnostic application - Market size and forecast 2023-2028 ($ billion)
Exhibits 35: Data Table on Diagnostic application - Market size and forecast 2023-2028 ($ billion)
Exhibits 36: Chart on Diagnostic application - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Diagnostic application - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Research application - Market size and forecast 2023-2028 ($ billion)
Exhibits 39: Data Table on Research application - Market size and forecast 2023-2028 ($ billion)
Exhibits 40: Chart on Research application - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Research application - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Forensic application - Market size and forecast 2023-2028 ($ billion)
Exhibits 43: Data Table on Forensic application - Market size and forecast 2023-2028 ($ billion)
Exhibits 44: Chart on Forensic application - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Forensic application - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by Application ($ billion)
Exhibits 47: Data Table on Market opportunity by Application ($ billion)
Exhibits 48: Chart on End-user - Market share 2023-2028 (%)
Exhibits 49: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 50: Chart on Comparison by End-user
Exhibits 51: Data Table on Comparison by End-user
Exhibits 52: Chart on Hospitals and diagnostic laboratories - Market size and forecast 2023-2028 ($ billion)
Exhibits 53: Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2023-2028 ($ billion)
Exhibits 54: Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
Exhibits 57: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
Exhibits 58: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
Exhibits 60: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 61: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 62: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 63: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 64: Market opportunity by End-user ($ billion)
Exhibits 65: Data Table on Market opportunity by End-user ($ billion)
Exhibits 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 69: Chart on Geographic comparison
Exhibits 70: Data Table on Geographic comparison
Exhibits 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibits 96: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibits 97: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 107: Market opportunity By Geographical Landscape ($ billion)
Exhibits 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 109: Impact of drivers and challenges in 2023 and 2028
Exhibits 110: Overview on Criticality of inputs and Factors of differentiation
Exhibits 111: Overview on factors of disruption
Exhibits 112: Impact of key risks on business
Exhibits 113: Vendors covered
Exhibits 114: Matrix on vendor position and classification
Exhibits 115: Agilent Technologies Inc. - Overview
Exhibits 116: Agilent Technologies Inc. - Business segments
Exhibits 117: Agilent Technologies Inc. - Key news
Exhibits 118: Agilent Technologies Inc. - Key offerings
Exhibits 119: Agilent Technologies Inc. - Segment focus
Exhibits 120: Bio SB - Overview
Exhibits 121: Bio SB - Product/Service
Exhibits 122: Bio SB - Key offerings
Exhibits 123: Biocare Medical LLC - Overview
Exhibits 124: Biocare Medical LLC - Product/Service
Exhibits 125: Biocare Medical LLC - Key offerings
Exhibits 126: BioGenex Laboratories Inc. - Overview
Exhibits 127: BioGenex Laboratories Inc. - Product/Service
Exhibits 128: BioGenex Laboratories Inc. - Key offerings
Exhibits 129: CANDOR Bioscience GmbH - Overview
Exhibits 130: CANDOR Bioscience GmbH - Product/Service
Exhibits 131: CANDOR Bioscience GmbH - Key offerings
Exhibits 132: Cell Signaling Technology Inc. - Overview
Exhibits 133: Cell Signaling Technology Inc. - Product/Service
Exhibits 134: Cell Signaling Technology Inc. - Key offerings
Exhibits 135: Danaher Corp. - Overview
Exhibits 136: Danaher Corp. - Business segments
Exhibits 137: Danaher Corp. - Key news
Exhibits 138: Danaher Corp. - Key offerings
Exhibits 139: Danaher Corp. - Segment focus
Exhibits 140: Elabscience Biotechnology Inc. - Overview
Exhibits 141: Elabscience Biotechnology Inc. - Product/Service
Exhibits 142: Elabscience Biotechnology Inc. - Key offerings
Exhibits 143: F. Hoffmann La Roche Ltd. - Overview
Exhibits 144: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 145: F. Hoffmann La Roche Ltd. - Key news
Exhibits 146: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 147: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 148: Lunaphore Technologies SA - Overview
Exhibits 149: Lunaphore Technologies SA - Product/Service
Exhibits 150: Lunaphore Technologies SA - Key offerings
Exhibits 151: Merck KGaA - Overview
Exhibits 152: Merck KGaA - Business segments
Exhibits 153: Merck KGaA - Key news
Exhibits 154: Merck KGaA - Key offerings
Exhibits 155: Merck KGaA - Segment focus
Exhibits 156: Miltenyi Biotec B.V. and Co. KG - Overview
Exhibits 157: Miltenyi Biotec B.V. and Co. KG - Product/Service
Exhibits 158: Miltenyi Biotec B.V. and Co. KG - Key offerings
Exhibits 159: SAKURA SEIKI Co. Ltd. - Overview
Exhibits 160: SAKURA SEIKI Co. Ltd. - Product/Service
Exhibits 161: SAKURA SEIKI Co. Ltd. - Key offerings
Exhibits 162: Takara Holdings Inc. - Overview
Exhibits 163: Takara Holdings Inc. - Business segments
Exhibits 164: Takara Holdings Inc. - Key offerings
Exhibits 165: Takara Holdings Inc. - Segment focus
Exhibits 166: Thermo Fisher Scientific Inc. - Overview
Exhibits 167: Thermo Fisher Scientific Inc. - Business segments
Exhibits 168: Thermo Fisher Scientific Inc. - Key news
Exhibits 169: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 170: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 171: Inclusions checklist
Exhibits 172: Exclusions checklist
Exhibits 173: Currency conversion rates for US$
Exhibits 174: Research methodology
Exhibits 175: Validation techniques employed for market sizing
Exhibits 176: Information sources
Exhibits 177: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global immunohistochemistry market: Agilent Technologies Inc., Bio Rad Laboratories Inc., Bio SB, Bio Techne Corp., Biocare Medical LLC, BioGenex Laboratories Inc., CANDOR Bioscience GmbH, Cell Signaling Technology Inc., Danaher Corp., Eagle Biosciences Inc., Elabscience Biotechnology Inc., F. Hoffmann La Roche Ltd., Lunaphore Technologies SA, Merck KGaA, Miltenyi Biotec B.V. and Co. KG, PerkinElmer Inc., Takara Holdings Inc., Thermo Fisher Scientific Inc., PHC Holdings Corp., and SAKURA SEIKI Co. Ltd..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is automation and digitalization of immunohistochemistry processes.'

According to the report, one of the major drivers for this market is the increasing number of cancer patients globally.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Agilent Technologies Inc.
Bio Rad Laboratories Inc.
Bio SB
Bio Techne Corp.
Biocare Medical LLC
BioGenex Laboratories Inc.
CANDOR Bioscience GmbH
Cell Signaling Technology Inc.
Danaher Corp.
Eagle Biosciences Inc.
Elabscience Biotechnology Inc.
F. Hoffmann La Roche Ltd.
Lunaphore Technologies SA
Merck KGaA
Miltenyi Biotec B.V. and Co. KG
PerkinElmer Inc
PHC Holdings Corp.
SAKURA SEIKI Co. Ltd.
Takara Holdings Inc.
Thermo Fisher Scientific Inc.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2379EUR$2,500USD£1,997GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3807EUR$4,000USD£3,196GBP

The immunohistochemistry market is segmented as below:

By Application

By End-user

By Geographical Landscape

The report on the immunohistochemistry market covers the following areas:

Table of Contents

Executive Summary

Companies Mentioned (Partial List)

Related Topics

Related Reports

Immunohistochemistry (IHC) - Market Insights, Competitive Landscape, and Market Forecast- 2030

Immunohistochemistry Market by Product, Disease Type, End-user, Application - Global Forecast 2025-2030

Immunohistochemistry (IHC) Global Market Report 2024

Immunohistochemistry (IHC) Market by Product (Antibodies (Type, Clonality), Reagents, Equipment, Kits, Software), Application (Diagnostics (Cancer, Infectious, Autoimmune, Neurological), Research (Drug Development), Forensic) - Global Forecast to 2029

Companion Diagnostics Market by Technology, Indication, End-user - Global Forecast 2025-2030